131 related articles for article (PubMed ID: 28301933)
1. Ferritin Decorated PLGA/Paclitaxel Loaded Nanoparticles Endowed with an Enhanced Toxicity Toward MCF-7 Breast Tumor Cells.
Turino LN; Ruggiero MR; Stefanìa R; Cutrin JC; Aime S; Geninatti Crich S
Bioconjug Chem; 2017 Apr; 28(4):1283-1290. PubMed ID: 28301933
[TBL] [Abstract][Full Text] [Related]
2. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
[TBL] [Abstract][Full Text] [Related]
3. Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells.
Geninatti Crich S; Cadenazzi M; Lanzardo S; Conti L; Ruiu R; Alberti D; Cavallo F; Cutrin JC; Aime S
Nanoscale; 2015 Apr; 7(15):6527-33. PubMed ID: 25786779
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.
Mattu C; Pabari RM; Boffito M; Sartori S; Ciardelli G; Ramtoola Z
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):463-72. PubMed ID: 23916461
[TBL] [Abstract][Full Text] [Related]
5. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells.
Jin C; Bai L; Wu H; Song W; Guo G; Dou K
Pharm Res; 2009 Jul; 26(7):1776-84. PubMed ID: 19384463
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
[TBL] [Abstract][Full Text] [Related]
8. Design of PLGA based nanoparticles for imaging guided applications.
Mariano RN; Alberti D; Cutrin JC; Geninatti Crich S; Aime S
Mol Pharm; 2014 Nov; 11(11):4100-6. PubMed ID: 25225751
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone peptide tethered nanoparticulate system for enhanced antitumoral efficacy of paclitaxel.
Ghanghoria R; Tekade RK; Mishra AK; Chuttani K; Jain NK
Nanomedicine (Lond); 2016 Apr; 11(7):797-816. PubMed ID: 26980704
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
Abouelmagd SA; Ku YJ; Yeo Y
J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
[TBL] [Abstract][Full Text] [Related]
11. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
12. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
13. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
14. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells.
Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C
Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251
[TBL] [Abstract][Full Text] [Related]
15. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.
Swaminathan SK; Roger E; Toti U; Niu L; Ohlfest JR; Panyam J
J Control Release; 2013 Nov; 171(3):280-7. PubMed ID: 23871962
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
Chen J; Li S; Shen Q; He H; Zhang Y
Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
[TBL] [Abstract][Full Text] [Related]
17. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
18. [Effects of modification of transferrin on cytotoxicity and intracellular delivery of paclitaxel loaded PLGA nanoparticles].
Jin SH; Li NC; Zhang ZH; Na YQ
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3151-4. PubMed ID: 23328431
[TBL] [Abstract][Full Text] [Related]
19. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts.
Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS
Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.
López-Gasco P; Iglesias I; Benedí J; Lozano R; Teijón JM; Blanco MD
J Microencapsul; 2011; 28(5):417-29. PubMed ID: 21736526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]